Search research articles
Contact Us
Filters
Showing results (21-30 of 476) with videos related to
Page
of 48
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2002
Challenge of locally persistent prostate cancer: an unresolved clinical dilemma
Christopher J Logothetis
Seminars in Oncology
|
October 23, 2003
The case for a biologically based classification of prostate cancer
Christopher J Logothetis
BJU International
|
May 20, 2011
When 'dueling technologies' are mistaken for progress
Christopher J Logothetis
Oncology (Williston Park, N.Y.)
|
July 11, 2002
Docetaxel in the integrated management of prostate cancer. Current applications and future promise
Christopher J Logothetis
The Journal of Urology
|
May 28, 2013
Treatment of castrate-resistant prostate cancer
Christopher J Logothetis
The New England Journal of Medicine
|
July 27, 2017
Improved Outcomes in Men with Advanced Prostate Cancer
Christopher J Logothetis
European Urology
|
June 11, 2013
Re: intratumor heterogeneity and branched evolution revealed by multiregion sequencing
Christopher J Logothetis
The Prostate
|
July 30, 2003
Foundation for the integration of biologically based therapy in the management of prostate cancer
Christopher J Logothetis
Lancet (London, England)
|
November 19, 2011
Treatment of prostate cancer metastases: more than semantics
Christopher J Logothetis
The Lancet. Oncology
|
May 20, 2014
Prostate cancer bone metastases: not so systemic after all
Christopher J Logothetis
Page
of 48
Search research articles
Search
Showing results (21-30 of 476) with videos related to
Sort By:
Page
of 48
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2002
Challenge of locally persistent prostate cancer: an unresolved clinical dilemma
Christopher J Logothetis
Seminars in Oncology
|
October 23, 2003
The case for a biologically based classification of prostate cancer
Christopher J Logothetis
BJU International
|
May 20, 2011
When 'dueling technologies' are mistaken for progress
Christopher J Logothetis
Oncology (Williston Park, N.Y.)
|
July 11, 2002
Docetaxel in the integrated management of prostate cancer. Current applications and future promise
Christopher J Logothetis
The Journal of Urology
|
May 28, 2013
Treatment of castrate-resistant prostate cancer
Christopher J Logothetis
The New England Journal of Medicine
|
July 27, 2017
Improved Outcomes in Men with Advanced Prostate Cancer
Christopher J Logothetis
European Urology
|
June 11, 2013
Re: intratumor heterogeneity and branched evolution revealed by multiregion sequencing
Christopher J Logothetis
The Prostate
|
July 30, 2003
Foundation for the integration of biologically based therapy in the management of prostate cancer
Christopher J Logothetis
Lancet (London, England)
|
November 19, 2011
Treatment of prostate cancer metastases: more than semantics
Christopher J Logothetis
The Lancet. Oncology
|
May 20, 2014
Prostate cancer bone metastases: not so systemic after all
Christopher J Logothetis
Page
of 48